Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions

The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured gluco...

Full description

Saved in:
Bibliographic Details
Published inEndocrinology and metabolism (Seoul) Vol. 29; no. 3; pp. 363 - 370
Main Authors Sha, Jie, Lee, Jung Ok, Kim, Nami, Lee, Soo Kyung, Kim, Ji Hae, Moon, Ji Wook, Kim, Su Jin, Lee, Hye Jeong, Choi, Jong-Il, Park, Sun Hwa, Kim, Hyeon Soo
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Endocrine Society 01.09.2014
대한내분비학회
Subjects
Online AccessGet full text
ISSN2093-596X
2093-5978
DOI10.3803/EnM.2014.29.3.363

Cover

Abstract The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
AbstractList The role of small GTPase molecules is poorly understood under high glucose conditions.BACKGROUNDThe role of small GTPase molecules is poorly understood under high glucose conditions.We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.METHODSWe analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.RESULTSWe showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.CONCLUSIONThese results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
Background: The role of small GTPase molecules is poorly understood under high glucose conditions. Methods: We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. Results: We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. Conclusion: These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation. KCI Citation Count: 1
The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose. We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake. These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
BackgroundThe role of small GTPase molecules is poorly understood under high glucose conditions.MethodsWe analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.ResultsWe showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.ConclusionThese results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.
Author Kim, Hyeon Soo
Kim, Ji Hae
Lee, Jung Ok
Choi, Jong-Il
Lee, Soo Kyung
Kim, Su Jin
Moon, Ji Wook
Sha, Jie
Lee, Hye Jeong
Kim, Nami
Park, Sun Hwa
AuthorAffiliation 1 Department of Anatomy, Korea University College of Medicine, Seoul, Korea
3 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
2 Bando Hospital, Korea
AuthorAffiliation_xml – name: 3 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
– name: 1 Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– name: 2 Bando Hospital, Korea
Author_xml – sequence: 1
  givenname: Jie
  surname: Sha
  fullname: Sha, Jie
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 3
  givenname: Jung Ok
  surname: Lee
  fullname: Lee, Jung Ok
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 4
  givenname: Nami
  surname: Kim
  fullname: Kim, Nami
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 5
  givenname: Soo Kyung
  surname: Lee
  fullname: Lee, Soo Kyung
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 6
  givenname: Ji Hae
  surname: Kim
  fullname: Kim, Ji Hae
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 7
  givenname: Ji Wook
  surname: Moon
  fullname: Moon, Ji Wook
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 8
  givenname: Su Jin
  surname: Kim
  fullname: Kim, Su Jin
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 9
  givenname: Hye Jeong
  surname: Lee
  fullname: Lee, Hye Jeong
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 10
  givenname: Jong-Il
  surname: Choi
  fullname: Choi, Jong-Il
  organization: Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea
– sequence: 11
  givenname: Sun Hwa
  surname: Park
  fullname: Park, Sun Hwa
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
– sequence: 12
  givenname: Hyeon Soo
  surname: Kim
  fullname: Kim, Hyeon Soo
  organization: Department of Anatomy, Korea University College of Medicine, Seoul, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25309796$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001920407$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp1Uk1rGzEQFSWlSd38gF7KHnuIt_rY1UqXgjGOY0hpMWnpTWj1YSuRJUfyBvLvK9tN2hQqBDOM3ryZ0by34CTEYAB4j2BNGCSfZuFLjSFqasxrUhNKXoEzDDkZt7xjJ88-_XkKznO-heUw1iCM3oBT3BLIO07PwOKHfCAXlazms8vKxlQt13FyUX3z8jGX6DS5nVPSV8voTTUEbVJ15Vbrau4HFbOppjHoAokhvwOvrfTZnP-2I_D9cnYzvRpff50vppPrsWoQIWPdyNZCbUzHMIaqsajVHPGuJZrInlKiMOlNzzppOeyZlFpjamQPO0MpxZqMwMcjb0hW3CknonQHu4riLonJ8mYhOtrwMuMILI5QHeWt2Ca3kenxgD8EYloJmcp83gikKSS90khB3rRWMYsVU6ZD5de0paZwfT5ybYd-Y7QyYZekf0H68iW4dWnpQTSIY4bJn763Kd4PJu_ExmVlvJfBxCELRFG5jHNWoB_-rvVc5GltBdAdASrFnJOxQrmd3K-hlHZeICj2GhFFI2KvEYG5IKJopGSifzKfyP-f8wvtY7y3
CitedBy_id crossref_primary_10_3390_cells10040915
crossref_primary_10_1038_srep41875
crossref_primary_10_1016_j_bcp_2022_115321
crossref_primary_10_3803_EnM_2015_30_1_47
crossref_primary_10_3389_fncel_2021_661612
crossref_primary_10_1016_j_apsb_2023_03_018
crossref_primary_10_1016_j_bbadis_2024_167236
Cites_doi 10.1096/fj.09-137380
10.1073/pnas.93.16.8431
10.1128/MCB.20.17.6364-6373.2000
10.1007/s10557-008-6092-0
10.1128/MCB.20.5.1461-1477.2000
10.1016/j.ejphar.2009.09.003
10.1016/j.metabol.2007.06.005
10.1210/me.2003-0294
10.1016/S0960-9822(07)00559-3
10.1152/ajpcell.00269.2006
10.1001/archinternmed.2009.20
10.2337/diabetes.51.10.2886
10.1126/science.279.5350.558
10.1016/S0024-3205(01)01225-5
10.1111/j.1742-1241.2004.00318.x
10.1152/ajpendo.00167.2001
10.1042/0264-6021:3480083
10.2337/db06-0823
10.1128/MCB.11.4.1912
10.1111/j.1469-1809.1995.tb01603.x
10.1042/BC20070160
10.1074/jbc.271.13.7544
10.1152/ajpendo.00254.2001
10.1016/j.cell.2009.03.016
10.1016/S0092-8674(04)00003-0
10.1161/01.RES.80.4.482
10.1111/j.1432-1033.1997.00259.x
10.1073/pnas.252625599
10.1096/fasebj.9.7.7737463
10.1002/j.1460-2075.1989.tb08354.x
ContentType Journal Article
Copyright Copyright © 2014 Korean Endocrine Society 2014
Copyright_xml – notice: Copyright © 2014 Korean Endocrine Society 2014
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.3803/EnM.2014.29.3.363
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2093-5978
EndPage 370
ExternalDocumentID oai_kci_go_kr_ARTI_764925
oai_doaj_org_article_1d603bcd1c0945fc8f2c8ce71008df6e
PMC4192823
25309796
10_3803_EnM_2014_29_3_363
Genre Journal Article
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: NRF-2013R1A2A2A05004796
GroupedDBID 5-W
53G
5VS
8JR
8XY
AAYXX
ABDBF
ACUHS
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EF.
GROUPED_DOAJ
HYE
HZB
IPNFZ
KQ8
M48
OK1
PGMZT
RIG
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c4133-d4a5f0dee78220c4f15d919753d3ab663c23beb87af90b8aadd26eab07e6662d3
IEDL.DBID M48
ISSN 2093-596X
IngestDate Tue Nov 21 21:43:00 EST 2023
Wed Aug 27 01:28:52 EDT 2025
Thu Aug 21 18:12:07 EDT 2025
Thu Jul 10 23:05:48 EDT 2025
Wed Feb 19 01:55:45 EST 2025
Tue Jul 01 01:37:45 EDT 2025
Thu Apr 24 23:07:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Vav3
AMP-activated protein kinases
Diabetes
Metformin
High glucose
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4133-d4a5f0dee78220c4f15d919753d3ab663c23beb87af90b8aadd26eab07e6662d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
G704-001505.2014.29.3.020
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3803/EnM.2014.29.3.363
PMID 25309796
PQID 1611618998
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_764925
doaj_primary_oai_doaj_org_article_1d603bcd1c0945fc8f2c8ce71008df6e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4192823
proquest_miscellaneous_1611618998
pubmed_primary_25309796
crossref_citationtrail_10_3803_EnM_2014_29_3_363
crossref_primary_10_3803_EnM_2014_29_3_363
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20140901
PublicationDateYYYYMMDD 2014-09-01
PublicationDate_xml – month: 9
  year: 2014
  text: 20140901
  day: 1
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Endocrinology and metabolism (Seoul)
PublicationTitleAlternate Endocrinol Metab (Seoul)
PublicationYear 2014
Publisher Korean Endocrine Society
대한내분비학회
Publisher_xml – name: Korean Endocrine Society
– name: 대한내분비학회
References Hardie (10.3803/EnM.2014.29.3.363_ref13) 1997; 246
Han (10.3803/EnM.2014.29.3.363_ref28) 1998; 279
Henin (10.3803/EnM.2014.29.3.363_ref17) 1995; 9
Katzav (10.3803/EnM.2014.29.3.363_ref33) 1989; 8
Henske (10.3803/EnM.2014.29.3.363_ref36) 1995; 59
Despres (10.3803/EnM.2014.29.3.363_ref2) 2003; 29
Miranti (10.3803/EnM.2014.29.3.363_ref31) 1998; 8
Ju (10.3803/EnM.2014.29.3.363_ref19) 2007; 292
JeBailey (10.3803/EnM.2014.29.3.363_ref24) 2007; 56
Katzav (10.3803/EnM.2014.29.3.363_ref35) 1991; 11
Iglesias (10.3803/EnM.2014.29.3.363_ref20) 2002; 51
Bustelo (10.3803/EnM.2014.29.3.363_ref27) 2000; 20
Zheng (10.3803/EnM.2014.29.3.363_ref32) 1996; 93
Pryor (10.3803/EnM.2014.29.3.363_ref11) 2000; 348
Fisher (10.3803/EnM.2014.29.3.363_ref18) 2002; 282
Wang (10.3803/EnM.2014.29.3.363_ref12) 2007; 38
Ueda (10.3803/EnM.2014.29.3.363_ref25) 2008; 100
Ai (10.3803/EnM.2014.29.3.363_ref15) 2002; 282
Gotoh (10.3803/EnM.2014.29.3.363_ref30) 1997; 8
Borst (10.3803/EnM.2014.29.3.363_ref6) 2001; 69
Zong (10.3803/EnM.2014.29.3.363_ref16) 2002; 99
Moores (10.3803/EnM.2014.29.3.363_ref26) 2000; 20
JeBailey (10.3803/EnM.2014.29.3.363_ref23) 2004; 18
Siegel (10.3803/EnM.2014.29.3.363_ref1) 1999
Ueda (10.3803/EnM.2014.29.3.363_ref22) 2010; 24
Cichowski (10.3803/EnM.2014.29.3.363_ref29) 1996; 271
He (10.3803/EnM.2014.29.3.363_ref8) 2009; 137
Burridge (10.3803/EnM.2014.29.3.363_ref21) 2004; 116
Bailey (10.3803/EnM.2014.29.3.363_ref3) 2004; 58
Yoshida (10.3803/EnM.2014.29.3.363_ref9) 2009; 623
Teranishi (10.3803/EnM.2014.29.3.363_ref7) 2007; 56
Wiernsperger (10.3803/EnM.2014.29.3.363_ref10) 1999; 25
Bailey (10.3803/EnM.2014.29.3.363_ref4) 2008; 22
Adams (10.3803/EnM.2014.29.3.363_ref34) 1992; 7
Makinde (10.3803/EnM.2014.29.3.363_ref14) 1997; 80
Kooy (10.3803/EnM.2014.29.3.363_ref5) 2009; 169
Schuebel (10.3803/EnM.2014.29.3.363_ref37) 1996; 13
12351423 - Diabetes. 2002 Oct;51(10):2886-94
2005887 - Mol Cell Biol. 1991 Apr;11(4):1912-20
11554611 - Life Sci. 2001 Aug 17;69(13):1497-507
14615606 - Mol Endocrinol. 2004 Feb;18(2):359-72
19307526 - Arch Intern Med. 2009 Mar 23;169(6):616-25
9438848 - Science. 1998 Jan 23;279(5350):558-60
16870829 - Am J Physiol Cell Physiol. 2007 Jan;292(1):C564-72
19450513 - Cell. 2009 May 15;137(4):635-46
9843681 - Curr Biol. 1998 Dec 3;8(24):1289-99
9118478 - Circ Res. 1997 Apr;80(4):482-9
10794717 - Biochem J. 2000 May 15;348 Pt 1:83-91
18482007 - Biol Cell. 2008 Nov;100(11):645-57
8710375 - Oncogene. 1996 Jul 18;13(2):363-71
10938113 - Mol Cell Biol. 2000 Sep;20(17):6364-73
17953367 - Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):819-21
17884455 - Metabolism. 2007 Oct;56(10):1418-24
2477241 - EMBO J. 1989 Aug;8(8):2283-90
9208914 - Eur J Biochem. 1997 Jun 1;246(2):259-73
8631786 - J Biol Chem. 1996 Mar 29;271(13):7544-50
15529521 - Int J Clin Pract. 2004 Sep;58(9):867-76
11739078 - Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23
18288595 - Cardiovasc Drugs Ther. 2008 Jun;22(3):215-24
8710888 - Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8431-6
14744429 - Cell. 2004 Jan 23;116(2):167-79
19765581 - Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7
17259384 - Diabetes. 2007 Feb;56(2):394-403
9186005 - Cell Growth Differ. 1997 Jun;8(6):721-9
10669724 - Mol Cell Biol. 2000 Mar;20(5):1461-77
12006359 - Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1291-300
10443322 - Diabetes Metab. 1999 Jun;25(2):110-27
14502101 - Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61
20203090 - FASEB J. 2010 Jul;24(7):2254-61
1565462 - Oncogene. 1992 Apr;7(4):611-8
7737463 - FASEB J. 1995 Apr;9(7):541-6
12444247 - Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15983-7
7762982 - Ann Hum Genet. 1995 Jan;59(Pt 1):25-37
References_xml – volume: 24
  start-page: 2254
  year: 2010
  ident: 10.3803/EnM.2014.29.3.363_ref22
  publication-title: FASEB J
  doi: 10.1096/fj.09-137380
– volume: 93
  start-page: 8431
  year: 1996
  ident: 10.3803/EnM.2014.29.3.363_ref32
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.16.8431
– volume: 20
  start-page: 6364
  year: 2000
  ident: 10.3803/EnM.2014.29.3.363_ref26
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.17.6364-6373.2000
– volume: 22
  start-page: 215
  year: 2008
  ident: 10.3803/EnM.2014.29.3.363_ref4
  publication-title: Cardiovasc Drugs Ther
  doi: 10.1007/s10557-008-6092-0
– volume: 20
  start-page: 1461
  year: 2000
  ident: 10.3803/EnM.2014.29.3.363_ref27
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.20.5.1461-1477.2000
– volume: 623
  start-page: 141
  year: 2009
  ident: 10.3803/EnM.2014.29.3.363_ref9
  publication-title: Eur J Pharmacol
  doi: 10.1016/j.ejphar.2009.09.003
– volume: 56
  start-page: 1418
  year: 2007
  ident: 10.3803/EnM.2014.29.3.363_ref7
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2007.06.005
– volume: 18
  start-page: 359
  year: 2004
  ident: 10.3803/EnM.2014.29.3.363_ref23
  publication-title: Mol Endocrinol
  doi: 10.1210/me.2003-0294
– volume: 8
  start-page: 1289
  year: 1998
  ident: 10.3803/EnM.2014.29.3.363_ref31
  publication-title: Curr Biol
  doi: 10.1016/S0960-9822(07)00559-3
– volume: 292
  start-page: C564
  year: 2007
  ident: 10.3803/EnM.2014.29.3.363_ref19
  publication-title: Am J Physiol Cell Physiol
  doi: 10.1152/ajpcell.00269.2006
– volume: 169
  start-page: 616
  year: 2009
  ident: 10.3803/EnM.2014.29.3.363_ref5
  publication-title: Arch Intern Med
  doi: 10.1001/archinternmed.2009.20
– volume: 51
  start-page: 2886
  year: 2002
  ident: 10.3803/EnM.2014.29.3.363_ref20
  publication-title: Diabetes
  doi: 10.2337/diabetes.51.10.2886
– volume: 279
  start-page: 558
  year: 1998
  ident: 10.3803/EnM.2014.29.3.363_ref28
  publication-title: Science
  doi: 10.1126/science.279.5350.558
– volume: 25
  start-page: 110
  year: 1999
  ident: 10.3803/EnM.2014.29.3.363_ref10
  publication-title: Diabetes Metab
– volume: 7
  start-page: 611
  year: 1992
  ident: 10.3803/EnM.2014.29.3.363_ref34
  publication-title: Oncogene
– volume: 13
  start-page: 363
  year: 1996
  ident: 10.3803/EnM.2014.29.3.363_ref37
  publication-title: Oncogene
– volume: 69
  start-page: 1497
  year: 2001
  ident: 10.3803/EnM.2014.29.3.363_ref6
  publication-title: Life Sci
  doi: 10.1016/S0024-3205(01)01225-5
– start-page: 637
  volume-title: Basic Neurochemistry
  year: 1999
  ident: 10.3803/EnM.2014.29.3.363_ref1
– volume: 8
  start-page: 721
  year: 1997
  ident: 10.3803/EnM.2014.29.3.363_ref30
  publication-title: Cell Growth Differ
– volume: 58
  start-page: 867
  year: 2004
  ident: 10.3803/EnM.2014.29.3.363_ref3
  publication-title: Int J Clin Pract
  doi: 10.1111/j.1742-1241.2004.00318.x
– volume: 282
  start-page: E1291
  year: 2002
  ident: 10.3803/EnM.2014.29.3.363_ref15
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00167.2001
– volume: 38
  start-page: 819
  year: 2007
  ident: 10.3803/EnM.2014.29.3.363_ref12
  publication-title: Sichuan Da Xue Xue Bao Yi Xue Ban
– volume: 348
  start-page: 83
  issue: Pt 1
  year: 2000
  ident: 10.3803/EnM.2014.29.3.363_ref11
  publication-title: Biochem J
  doi: 10.1042/0264-6021:3480083
– volume: 56
  start-page: 394
  year: 2007
  ident: 10.3803/EnM.2014.29.3.363_ref24
  publication-title: Diabetes
  doi: 10.2337/db06-0823
– volume: 11
  start-page: 1912
  year: 1991
  ident: 10.3803/EnM.2014.29.3.363_ref35
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.11.4.1912
– volume: 59
  start-page: 25
  issue: Pt 1
  year: 1995
  ident: 10.3803/EnM.2014.29.3.363_ref36
  publication-title: Ann Hum Genet
  doi: 10.1111/j.1469-1809.1995.tb01603.x
– volume: 100
  start-page: 645
  year: 2008
  ident: 10.3803/EnM.2014.29.3.363_ref25
  publication-title: Biol Cell
  doi: 10.1042/BC20070160
– volume: 271
  start-page: 7544
  year: 1996
  ident: 10.3803/EnM.2014.29.3.363_ref29
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.13.7544
– volume: 282
  start-page: E18
  year: 2002
  ident: 10.3803/EnM.2014.29.3.363_ref18
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00254.2001
– volume: 137
  start-page: 635
  year: 2009
  ident: 10.3803/EnM.2014.29.3.363_ref8
  publication-title: Cell
  doi: 10.1016/j.cell.2009.03.016
– volume: 29
  start-page: 6S53
  issue: 4 Pt 2
  year: 2003
  ident: 10.3803/EnM.2014.29.3.363_ref2
  publication-title: Diabetes Metab
– volume: 116
  start-page: 167
  year: 2004
  ident: 10.3803/EnM.2014.29.3.363_ref21
  publication-title: Cell
  doi: 10.1016/S0092-8674(04)00003-0
– volume: 80
  start-page: 482
  year: 1997
  ident: 10.3803/EnM.2014.29.3.363_ref14
  publication-title: Circ Res
  doi: 10.1161/01.RES.80.4.482
– volume: 246
  start-page: 259
  year: 1997
  ident: 10.3803/EnM.2014.29.3.363_ref13
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1997.00259.x
– volume: 99
  start-page: 15983
  year: 2002
  ident: 10.3803/EnM.2014.29.3.363_ref16
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.252625599
– volume: 9
  start-page: 541
  year: 1995
  ident: 10.3803/EnM.2014.29.3.363_ref17
  publication-title: FASEB J
  doi: 10.1096/fasebj.9.7.7737463
– volume: 8
  start-page: 2283
  year: 1989
  ident: 10.3803/EnM.2014.29.3.363_ref33
  publication-title: EMBO J
  doi: 10.1002/j.1460-2075.1989.tb08354.x
– reference: 12006359 - Am J Physiol Endocrinol Metab. 2002 Jun;282(6):E1291-300
– reference: 12351423 - Diabetes. 2002 Oct;51(10):2886-94
– reference: 10938113 - Mol Cell Biol. 2000 Sep;20(17):6364-73
– reference: 1565462 - Oncogene. 1992 Apr;7(4):611-8
– reference: 8710375 - Oncogene. 1996 Jul 18;13(2):363-71
– reference: 7762982 - Ann Hum Genet. 1995 Jan;59(Pt 1):25-37
– reference: 17259384 - Diabetes. 2007 Feb;56(2):394-403
– reference: 10794717 - Biochem J. 2000 May 15;348 Pt 1:83-91
– reference: 12444247 - Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15983-7
– reference: 14502101 - Diabetes Metab. 2003 Sep;29(4 Pt 2):6S53-61
– reference: 2477241 - EMBO J. 1989 Aug;8(8):2283-90
– reference: 19450513 - Cell. 2009 May 15;137(4):635-46
– reference: 8710888 - Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8431-6
– reference: 14744429 - Cell. 2004 Jan 23;116(2):167-79
– reference: 9208914 - Eur J Biochem. 1997 Jun 1;246(2):259-73
– reference: 9438848 - Science. 1998 Jan 23;279(5350):558-60
– reference: 2005887 - Mol Cell Biol. 1991 Apr;11(4):1912-20
– reference: 9843681 - Curr Biol. 1998 Dec 3;8(24):1289-99
– reference: 19307526 - Arch Intern Med. 2009 Mar 23;169(6):616-25
– reference: 11554611 - Life Sci. 2001 Aug 17;69(13):1497-507
– reference: 20203090 - FASEB J. 2010 Jul;24(7):2254-61
– reference: 9118478 - Circ Res. 1997 Apr;80(4):482-9
– reference: 17884455 - Metabolism. 2007 Oct;56(10):1418-24
– reference: 11739078 - Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E18-23
– reference: 10669724 - Mol Cell Biol. 2000 Mar;20(5):1461-77
– reference: 17953367 - Sichuan Da Xue Xue Bao Yi Xue Ban. 2007 Sep;38(5):819-21
– reference: 15529521 - Int J Clin Pract. 2004 Sep;58(9):867-76
– reference: 9186005 - Cell Growth Differ. 1997 Jun;8(6):721-9
– reference: 14615606 - Mol Endocrinol. 2004 Feb;18(2):359-72
– reference: 7737463 - FASEB J. 1995 Apr;9(7):541-6
– reference: 18482007 - Biol Cell. 2008 Nov;100(11):645-57
– reference: 16870829 - Am J Physiol Cell Physiol. 2007 Jan;292(1):C564-72
– reference: 18288595 - Cardiovasc Drugs Ther. 2008 Jun;22(3):215-24
– reference: 19765581 - Eur J Pharmacol. 2009 Nov 25;623(1-3):141-7
– reference: 8631786 - J Biol Chem. 1996 Mar 29;271(13):7544-50
– reference: 10443322 - Diabetes Metab. 1999 Jun;25(2):110-27
SSID ssj0000884121
Score 1.9863598
Snippet The role of small GTPase molecules is poorly understood under high glucose conditions. We analyzed the expression pattern of Vav3 in skeletal muscle C2C12...
The role of small GTPase molecules is poorly understood under high glucose conditions.BACKGROUNDThe role of small GTPase molecules is poorly understood under...
BackgroundThe role of small GTPase molecules is poorly understood under high glucose conditions.MethodsWe analyzed the expression pattern of Vav3 in skeletal...
Background: The role of small GTPase molecules is poorly understood under high glucose conditions. Methods: We analyzed the expression pattern of Vav3 in...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 363
SubjectTerms AMP-activated protein kinases
Diabetes
High glucose
Metformin
Original
Vav3
내과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3dSxwxEA_iU19EadXVtqTgk7hnNtl87KOVOz9AEdFybyGbjyoeu-XUQv_7zuzeHXeltC--7EI2gezMJDPDzPyGkANwcHwtpM514WRehhRy56qYFynx4HzpGcMC56trdX5fXo7leKnVF-aE9fDAPeGOi6CYqH0oPDgimHCUuDc-dqA0IamIty-osSVnqruDjSmLruiKg8uey0qN-5CmMEwcD5srTOoqB7waiIFQYkUpddj9oGqaafqb2fln9uSSOhptko2ZHUlP-v1vkbXYvCcX39xPcUQdPRuOKFij9PahPTmiNxP36xlG520N6G07iRSrx6YU8zzoWZ-3Tk9bDGCjIH4g96Ph3el5PuuVkHtQQyIPpZOJhRhR4zNfpkKGqsCq2SBcDWaF56KOtdEuVaw2Dq41rqKrmY7gwPAgtsl60zZxl1BpUvLcBxUQmoZr40MQLHKumfTwzAibE8v6GZA49rOYWHAokL4W6GuRvpZXVligb0YOF0t-9Cga_5r8FTmwmIgA2N0AiIWdiYX9n1hk5Avwzz75x249vr-39mlqwU24sFohJiPMmXPXwqHCSIlrYvv6bMEMxkYC4IpmZKfn9mI7XApW6UplRK_Iwcp-V780jw8dcDdG3A0Xe2_xg_vkHVKtT3f7SNZfpq_xE9hHL_Xn7ij8BsFeCj0
  priority: 102
  providerName: Directory of Open Access Journals
Title Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions
URI https://www.ncbi.nlm.nih.gov/pubmed/25309796
https://www.proquest.com/docview/1611618998
https://pubmed.ncbi.nlm.nih.gov/PMC4192823
https://doaj.org/article/1d603bcd1c0945fc8f2c8ce71008df6e
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001920407
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Endocrinology and Metabolism, 2014, 29(3), , pp.363-370
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: KQ8
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: DOA
  dateStart: 20050101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: ABDBF
  dateStart: 20120901
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: DIK
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVERR
  databaseName: KoreaMed Open Access
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: 5-W
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://koreamed.org/journals
  providerName: Korean Association of Medical Journal Editors
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: RPM
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2093-5978
  dateEnd: 20250831
  omitProxy: true
  ssIdentifier: ssj0000884121
  issn: 2093-596X
  databaseCode: M48
  dateStart: 20130301
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdd97KXsbEv76NosKdRZbJkWfbDGF1J2g4yRllG3oSsj7Y02K3TjvW_353thGWEsRcbZMkWdyfd_XynO0LeAcBxlVSa6dQqlvnombVlYGmMwluXOc7xgPP0a348y77M1XyHrLznAwGXW6Ed1pOatYvRr-u7T7DgPyLiLLj8MK6nGKOVjUQ5kiMJC-bqmmFdKfS_DkU27pH7oKsEyv10AADdXl0U0IqoTAC0Z6rM573rc_uLN5RXl-MfVFLdxm3m6d9Rln-orckj8nCwN-lBLyCPyU6on5CTH_an3KeWHo0nFKxWenreHOzTbwt7t4TWVfkDetosAsVTZi3FeBB61Me308MGHd0osE_JbDL-fnjMhpoKzIG6ksxnVkXuQ0DLgLsspsqXKZ6u9dJWYH44IatQFdrGkleFhe1P5MFWXAcAOsLLZ2S3burwglBVxOiE87nHFDZCF857yYMQmisH14TwFbGMGxKOY92LhQHggfQ1QF-D9DWiNNIAfRPyfj3kqs-28a_On5ED646YKLtraNozM6w7k_qcy8r51AGOxXi1KFzhQpfTyMc8JOQt8M9cuotuPN7PGnPZGoATJ0bnmLsR-qy4a2DxoUfF1qG5XRowl7HgAEDWhDzvub2ejlCSl7rME6I35GBjvptP6ovzLsE3euYLIV_-x3dfkQdIlD7q7TXZvWlvwxswk26qve73wl4n778BV7QOmg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vav3%2C+a+GEF+for+RhoA%2C+Plays+a+Critical+Role+under+High+Glucose+Conditions&rft.jtitle=Endocrinology+and+metabolism+%28Seoul%29&rft.au=Sha%2C+Jie&rft.au=Na%2C+Jungsik&rft.au=Lee%2C+Jung+Ok&rft.au=Kim%2C+Nami&rft.date=2014-09-01&rft.issn=2093-596X&rft.volume=29&rft.issue=3&rft.spage=363&rft_id=info:doi/10.3803%2FEnM.2014.29.3.363&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-596X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-596X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-596X&client=summon